7Baggers

TEAM Stock Cash Flow Statements

The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
     Operating Cash Flow  
     Investing Cash Flow  
     Financing Cash Flow  
     Net Income  
    Quarterly
     | 
    Annual
     
    20220930 20221231 20230331 20230630 20230930 20231231 20240331 -805.53-571.01-336.49-101.97132.55367.08601.6836.12Milllion
    Quarterly Cash Flow Statements
    Quarterly
     | 
    Annual
     
      Unit: USD2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 
               
        cash flows from operating activities:       
        net income97,221,000 -52,586,000 -31,883,000 -277,724,000 -4,006,000 -191,290,000 -13,741,000 
        adjustments to reconcile net income to net cash from operating activities:       
        depreciation and amortization6,452,000 1,928,000 15,084,000 45,400,000 47,000 856,000 14,620,000 
        stock-based compensation-7,326,000 54,264,000 235,581,000 684,660,000 -2,358,000 92,154,000 173,631,000 
        impairment charges for leases and leasehold improvements   0    
        deferred income taxes11,825,000 -13,931,000 5,313,000 9,118,000 -1,796,000 1,769,000 1,522,000 
        gain on a non-cash sale of a controlling interest of a subsidiary  -1,378,000   41,026,000 -43,092,000 
        net income (income) on strategic investments       
        net foreign currency gain-4,513,000 2,056,000 181,000 -10,436,000 2,026,000 1,422,000 -3,625,000 
        other258,000 22,000 132,000 225,000 1,268,000   
        changes in operating assets and liabilities, net of business combinations:       
        accounts receivable36,344,000 -265,651,000 109,488,000 -177,986,000 116,265,000 -169,119,000 61,314,000 
        prepaid expenses and other assets-35,500,000 22,570,000 -23,056,000 -23,067,000 -12,473,000 19,987,000 -22,677,000 
        accounts payable-5,421,000 66,673,000 -33,025,000 106,602,000 -46,287,000 -12,560,000 31,147,000 
        accrued expenses and other liabilities8,009,000 130,471,000 -71,331,000 -56,627,000 72,978,000 166,703,000 -108,443,000 
        deferred revenue165,829,000 180,250,000 -44,398,000 239,163,000 22,390,000 111,091,000 -9,845,000 
        net cash from operating activities275,796,000 122,638,000 166,956,000 515,742,000 201,844,000 58,083,000 92,442,000 
        cash flows from investing activities:       
        business combinations, net of cash acquired      -600,000 
        purchases of property and equipment-5,187,000 -1,664,000 -3,669,000 -22,961,000 1,349,000 12,456,000 -16,496,000 
        purchases of strategic investments-4,000,000 3,500,000 -3,750,000 -10,450,000 -7,900,000 7,250,000 -8,350,000 
        purchases of marketable securities      -10,000,000 
        proceeds from maturities of marketable securities46,850,000   47,700,000 7,500,000   
        proceeds from sales of marketable securities and strategic investments 21,634,000 19,879,000 621,000 -355,000   
        net cash from investing activities836,116,000 -805,527,000 -56,903,000 -15,825,000 594,000 20,211,000 -6,238,000 
        cash flows from financing activities:       
        principal payments of term loan facility0       
        repurchases of class a common stock66,396,000 -35,894,000 -65,879,000 -118,258,000    
        proceeds from other financing arrangements   1,583,000   1,572,000 
        net cash from financing activities66,396,000 -48,394,000 -65,879,000 -116,675,000   1,396,000 
        effect of foreign exchange rate changes on cash, cash equivalents and restricted cash-6,832,000 7,343,000 -3,280,000  -3,101,000 8,461,000 -4,939,000 
        net increase in cash, cash equivalents, and restricted cash1,171,476,000 -723,940,000 40,894,000 381,016,000 167,591,000 85,359,000 82,661,000 
        cash, cash equivalents, and restricted cash at beginning of period-683,046,000 40,894,000 2,103,915,000 -251,283,000 168,020,000 83,263,000 1,386,686,000 
        net decrease in cash and cash equivalents included in assets held for sale      602,000 
        cash, cash equivalents, and restricted cash at end of period488,430,000 -683,046,000 2,144,809,000 130,335,000 335,611,000 168,020,000 1,469,949,000 
        reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown in the condensed consolidated statements of cash flows above:       
        net income on strategic investments -4,806,000 6,248,000   -3,950,000 11,513,000 
        purchases of marketable securities and other investments -420,000 -69,363,000     
        cash and cash equivalents -683,033,000 2,143,530,000 130,333,000 335,602,000 168,044,000 1,468,571,000 
        restricted cash included in other non-current assets -13,000 1,279,000 2,000 9,000 -24,000 1,378,000 
        total cash, cash equivalents, and restricted cash -683,046,000 2,144,809,000 130,335,000 335,611,000 168,020,000 1,469,949,000 
        changes in operating assets and liabilities:       
        supplemental disclosures of cash flow information:       
        income taxes paid, net of refunds  44,054,000  -58,699,000 34,522,000 29,220,000 
        interest paid  16,147,000   1,238,000 5,575,000 
        non-cash investing and financing activities:       
        purchase of property and equipment included in accrued expenses and other current liabilities  2,482,000  -625,000 8,363,000 -6,978,000 
        repurchases of class a common stock included in accrued expenses and other current liabilities  3,628,000     
        net income on exchange derivative and capped call transactions       
        amortization of debt discount and issuance cost   353,000 1,000 -1,000 118,000 
        net gain on strategic investments   21,219,000    
        purchases of intangible assets       
        proceeds from term loan facility       
        payment of issuance costs for debt       
        repayment of exchangeable senior notes       
        proceeds from settlement of capped call transactions       
        effect of foreign exchange rate changes on cash and cash equivalents       
        net decrease (increase) in cash and cash equivalents included in assets held for sale       
        reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:       
        interest paid, net of hedging       
        proceeds from maturities of investments      28,950,000 
        proceeds from sale of strategic investments      258,000 
        proceeds from sales of marketable securities       
        other financing activities      -176,000